Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 801–900 of 1,000

1. Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
   Kazutoshi Murotomi, Shigeyuki Arai, Aki Suyama, Akira Harashima, Yoshihiro Nakajima · 2019 · Journal of Functional Foods
2. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice
   Seung Ah Hong, Ik‐Rak Jung, Sung‐E Choi, Yoonjung Hwang, Soojin Lee, Youngho Son, Yu Jung Heo, Rihua Cui, Seung Jin Han, Hae Jin Kim et al. · 2019 · Scientific Reports
3. Comprehensive bibliometric and visualized analysis of research on gut-liver axis published from 1998 to 2022
   Yongtian Wen, Tai Zhang, Beihua Zhang, Fengyun Wang, Xiuxiu Wei, Yuchen Wei, Xiangxue Ma, Xudong Tang · 2024 · Heliyon
4. Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
   Peijun Xu, Maoyun Liu, Miao Liu, Ai Shen · 2024 · BioScience Trends
5. Non-Alcoholic Fatty Steatohepatitis an Inflammatory Disorder Beyond the Liver
   Sergio Cerpa‐Cruz · 2013 · Journal of Clinical & Cellular Immunology
6. Nutritional and Dietary Interventions for Nonalcoholic Fatty Liver Disease
   Cindy X. Cai, Stella Carlos, Pejman Solaimani, Bansari J. Trivedi, Chuong T. Tran, Shobha Castelino‐Prabhu · 2019 · Elsevier eBooks
7. Lipidomic Determination of Serum Lipids by Ultra-High Performance Liquid Chromatography – Mass Spectrometry (UPLC-MS) for the Characterization of Nonalcoholic Fatty Liver Disease (NAFLD)
   Yuwei Liu, Xiaoling Zang, Kun Feng, Shousheng Liu, Jiayuan Zhang, Zhihua Lv, Yongning Xin, Mingming Yu · 2021 · Analytical Letters
8. Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-κB signaling pathway
   Tianqi Chen, Deng Yan-fang, Yanyan Wang, Yonghui Zhang · 2022 · Biochemical and Biophysical Research Communications
9. Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study
   Florian Koutny, Dagobert Wiemann, Alexander J. Eckert, Svenja Meyhöfer, Maria Fritsch, Angeliki Pappa, Susanna Wiegand, Marc Weyer, Michael Wurm, Daniel Weghuber et al. · 2024 · Journal of Pediatric Gastroenterology and Nutrition
10. Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model
    Yasufumi Toriniwa, Tomoyuki Saito, Katsuhiro Miyajima, Yukihito Ishii, Kinuko Uno, Tatsuya Maekawa, Tohru Matsui, Shinichi KUME, Takahisa Yamada, Takeshi Ohta · 2018 · Journal of Veterinary Medical Science
11. Mechanisms Associated with the Effect of Hypericum perforatum and Smilax cordifolia Aqueous Extracts on Hepatic Steatosis in Obese Rats: A Lipidomic Approach
    Iza Fernanda Pérez‐Ramírez, Marco A. Gallegos‐Corona, Laura González‐Dávalos, Ofelia Mora, Nuria Elizabeth Rocha‐Guzmán, Rosalía Reynoso‐Camacho · 2018 · European Journal of Lipid Science and Technology
12. Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1–induced steatosis
    Veronika Tillander, Akihiro Miniami, Michele Alves‐Bezerra, Rosalind Coleman, David E. Cohen · 2018 · Journal of Biological Chemistry
13. Fatty liver and nonalcoholic steatohepatitis
    Brent A. Neuschwander‐Tetri · 2011 · Elsevier eBooks
14. FGF-19 agonism for NASH: a short study of a long disease
    Michael Charlton · 2018 · The Lancet
15. Association Between Exercise and Treatment with Liraglutide in Obese Rats by Cafeteria Diet
    Daiane Didek, Maiara Mikuska Cordeiro, João Lucas de Paula Xavier, Paulo Roberto Ribeiro, Thiago Rentz, Gilson César Nobre Franco, Carla Cristine Kanunfre, Henriette Rosa de Oliveira Emilio, Dionízia Xavier Scomparin · 2019 · Brazilian Archives of Biology and Technology
16. Hepatic endoplasmic reticulum stress in obesity: Deeper insights into processes, but are they relevant to nonalcoholic steatohepatitis?
    Isabelle Anne Leclercq, Derrick M. Van Rooyen, Geoffrey C. Farrell, Kris V. Kowdley, Geoffrey William McCaughan, Christian Trautwein · 2010 · Hepatology
17. D-allulose enhances lipid oxidation in HepG2 cells via peroxisome proliferator-activated receptor α (PPARα)
    Firas Warda, Jennifer Batch, Lauren Graham, Michael John Haas, Arshag D. Mooradian · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
18. Interactions among nutrition, metabolism and the immune system in the context of starvation and nutrition-stimulated obesity
    Borros Arneth · 2025 · Nutrition and Diabetes
19. Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
    Davide Misceo, Gabriele Mocciaro, Simona D’Amore, Michèle Vacca · 2024 · Nutrition & Metabolism
20. Activation of SIK2 inhibits gluconeogenesis and alleviates lipogenesis‐induced inflammatory response by SIK2 ‐ CRTC2 ‐ ACC1 in hepatocytes of large yellow croaker ( Larimichthys crocea )
    Shangzhe Han, Xiaojun Xiang, Xinwen Zhang, Lin Ou, Qiangde Liu, Xiang Xu, Jinze Zhang, Tingting Hao, Jianlong Du, Yueru Li et al. · 2025 · The FASEB Journal
21. Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease
    Chunxia Wang, Robert Gordon Batey, Johji Yamahara, Yuhao Li · 2017 · Journal of Functional Foods
22. Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis
    James Phillip Esteban, Amon Asgharpour · 2020 · Gastroenterology Clinics of North America
23. Asociación e interacciones de la apnea obstructiva del sueño (AOS) y del síndrome de hipoventilación obesidad (SHO)
    Gonzalo Labarca T., Gloria Horta · 2021 · Revista Médica Clínica Las Condes
24. The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States
    Karn Wijarnpreecha · 2022 · Annals of Gastroenterology
25. The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD
    Changhui Yu, Shiming He, Nan Peng, Maobin Kuang, Xin Huang, Chao Wang, Guotai Sheng, Wei Wang, Guobo Xie, Yang Zou · 2025 · BMC Gastroenterology
26. SU5, a new Auraptene analog with improved metabolic stability, ameliorates nonalcoholic fatty liver disease in methionine‐ and choline‐deficient diet‐fed db/db mice
    Fen Wen, Dezhi Bian, Xudong Wu, Ruobing Liu, ChaoNan Wang, Jianhe Gan · 2022 · Chemical Biology & Drug Design
27. Methionine and Choline Deficient Diet-induced Non-Alcoholic Steatohepatitis in Rats: Role of Melatonin
    Mohammed A. Amin, Rania F. Ahmed, Dalia Osama Saleh · 2017 · Journal of Applied Pharmaceutical Science
28. Tumours and Tumour-Like Lesions
    Linda D. Ferrell, Sanjay Kakar, Luigi Terracciano, Aileen Wee · 2023 · Elsevier eBooks
29. Attenuation of glycation and biochemical aberrations in fructose‐loaded rats by polyphenol‐rich ethyl acetate fraction of Parkia biglobosa (jacq.) Benth. (Mimosaceae) leaves
    Christian Chiazor Chibuogwu, Rita Onyekachukwu Asomadu, Innocent Uzochukwu Okagu, Chinelo Chinenye Nkwocha, Ben Chibuzo Amadi · 2021 · Clinical Phytoscience
30. The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
    Fayed Attia Koutb Megahed, Xiaoling Zhou, Pingnan Sun, Marwa M. Elmaghrabi · 2021 · Egyptian Liver Journal
31. Does Interaction between Sleep Quality and Major Dietary Patterns Predicts Depression among Overweight and Obese Women in Iran?
    Be‐Ikuu Dominic Doglikuu, Abolghassem Djazayery, Atieh Mirzababaei, Seyedeh Forough Sajjadi, Negin Badruj, Khadijeh Mirzaei · 2021 · Iranian Journal of Public Health
32. Interaction Between Hepatocytes and Proximal Tubular Epithelial Cells in Hypoxia-induced Lipotoxicity
    Jongkwon Park, Yun Jung Heo, Soonjo Kwon · 2021 · Biotechnology and Bioprocess Engineering
33. Abnormalities in the Growth Hormone Axis and Risk of Nonalcoholic Steatohepatitis: Active Player or Innocent Bystander?
    Stavra A. Xanthakos, Nancy Abigail Crimmins, Steven D. Chernausek · 2014 · The Journal of Pediatrics
34. Economic value added--a framework for health care executive compensation.
    William O. Cleverley · 1993 · PubMed
35. Synergistic effects of human-origin novel postbiotic Bacteroides & Phocaeicola on obesity and thermogenesis in high-fat diet-induced metabolic dysfunction
    Liangliang Wu, Jing‐Hua Wang, S.-H. Park, Y. Cui, Kyungsun Han, Hojun Kim · 2025 · Beneficial Microbes
36. A physiological oxygen gradient liver-zonation-on-a-chip reveals HIF-2α intervention in hepatic lipotoxicity
    Yushen Wang, Xinyu Li, Junlei Han, Feng Kong, Zhipeng Xu, Huili Hu, Li Wang · 2025 · Acta Biomaterialia
37. Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
    Jing-Ru Song, Ziwei Gao, L. Lai, Jie Zhang, Bin-Bin Liu, Yi Sang, Si-Qi Chen, Jia-Chen Qi, Yujun Zhang, Huang Kai et al. · 2025 · BMC Gastroenterology
38. DHCR7 inhibition ameliorates MetALD and HCC in mice and human 3D liver spheroids
    Gen Yamamoto, Raquel Carvalho‐Gontijo Weber, Wonseok Lee, Vivian Zhang, Haeum Jang, Sadatsugu Sakane, Xiao Liu, Hyun Young Kim, David A. Brenner, Na Li et al. · 2025 · JHEP Reports
39. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study
    Nina Bastati, Matthias Perkonigg, Daniel Sobotka, Sarah Poetter‐Lang, Romana Fragner, Andrea Beer, Alina Messner, Martin L. Watzenboeck, Svitlana Pochepnia, Jakob Kittinger et al. · 2023 · European Radiology
40. Hypertriglyceridemic hyperapoB and the development and resolution of nonalcoholic fatty liver disease: a cohort study
    Yiying Wang, Lijie Kong, Chaojie Ye, Chun Dou, Mian Li, Zhiyun Zhao, Yu Xu, Jieli Lu, Yuhong Chen, Min Xu et al. · 2023 · Journal of Lipid Research
41. Probable targets and mechanism of ginsenoside Rg1 for non-alcoholic fatty liver disease: a study integrating network pharmacology, molecular docking, and molecular dynamics simulation
    Danni Wang, Jia Zhang, Haifeng Dai, Kexin Tong, Mingjing Chen, Jiayi Peng, Wenxiang Huang · 2023 · Journal of Biomolecular Structure and Dynamics
42. Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats
    Maitane González-Arceo, Leixuri Aguirre, Maria Teresa Macarulla, Clàudia Gil‐Pitarch, Maria Luz Martínez‐Chantar, María P. Portillo, Saioa Gómez‐Zorita · 2024 · Antioxidants
43. Tratamiento con vitamina E en pacientes con esteatohepatitis no alcohólica Vitamin E
    Jhonathan Ferney Vélez M, Gustavo Amador Crespo H, Juan Carlos Restrepo · 2014 · Revista Colombiana de Gastroenterología
44. Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation.
    Maria Embgenbroich, Hendrik J.P. van der Zande, Anna Zawistowska‐Deniziak, Lisa R. Hoving, Karin de Ruiter, Marjolein A. Wijngaarden, Hanno Pijl, Willems van Dijk, Ko, Bart Everts, Vanessa van Harmelen et al. · 2021 · DZNE Pub
45. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population
    Weining Xie, Shengxin Chen · 2020 · Medicine
46. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
    Yang Zhang, Junxiang Li, Yan Zhang, Yunliang Wang · 2021 · World Journal of Clinical Cases
47. Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching
    Rong-Rong Zhu, Xuping Gao, Minqi Liao, Yunfeng Cui, Si-Xian Tan, Fangfang Zeng, Yanmei Lou, Changyi Wang, Shan Xu, Xiaolin Peng et al. · 2022 · Frontiers in Endocrinology
48. The Effect of Synthetic Curcumin Analogues on Obesity, Diabetes and Cardiovascular Disease: A Literature Review
    Salime Lavian, Pegah Mardaneh, Mohammad Bagherniya, Seyed Ahmad Emami, Alexandra E. Butler, Amirhossein Sahebkar · 2023 · Current Medicinal Chemistry
49. Early-Life Exposure to Lipopolysaccharide Induces Persistent Changes in Gene Expression Profiles in the Liver and Spleen of Female FVB/N Mice
    Elda Dervishi, Dagnachew Hailemariam, Seyed Ali Goldansaz, Burim Namik Ametaj · 2023 · Veterinary Sciences
50. lnc-HC ameliorates steatosis by promoting miR-130b-3p biogenesis and the assembly of an RNA-induced silencing complex
    Xi Lan, Jiajun Ren, Xiaojuan Du, Lin Zhang, Shuaishuai Wang, Xudong Yang, Shemin Lu · 2023 · Molecular and Cellular Endocrinology
51. L’autophagie dans les maladies chroniques du foie
    Philippe Gual, Hélène Gilgenkrantz, Sophie Lotersztajn · 2017 · médecine/sciences
52. Tea Polyphenol–Zinc Nanocomplexes Alleviate Diquat-Induced Liver and Small Intestine Oxidative Stress in C57BL/6 Mice
    Tingting Liu, Yang Zhao, Jie Feng · 2025 · Nanomaterials
53. Comparison and Characteristics of MASLD Mouse Models
    Li Wei, 高春辰, Hongyan Qin · 2026 · Biomedicines
54. A comparison of the biological activities of ethyl acetate fractions from the stems and leaves of Penthorum chinense Pursh
    Zhaolei WANG, Kai JIANG, Qinchao Ding, Shujun Liu, Xiaobing Dou, Bin Ding · 2019 · Frontiers of Agricultural Science and Engineering
55. Urinary C-peptide creatinine ratio is a significant indicator of non-alcoholic fatty liver disease in children with obesity
    Hekma Saad Farghaly, Kotb Abbass Metwalley, Yasser Ashraf Gamal, Ghada Mohamed Saied, Yasser Farouk Abdel-Raheem · 2022 · The Turkish Journal of Pediatrics
56. Dietary acid load and cirrhosis-related mortality: a prospective cohort study
    Fereshteh Pashayee-Khamene, Zeinab Heidari, Danial Fotros, Azita Hekmatdoost, Sara Karimi, Saleheh Ahmadzadeh, Mehdi Saberifiroozi, Behzad Hatami, Zahra Yari · 2024 · Scientific Reports
57. Effects of α-lipoic acid supplementation in a high-fat diet on growth, lipid metabolism and mitochondrial function in spotted seabass (Lateolabrax maculatus)
    Shan-pei Gan, Wenwen Huang, Xiaojiang Mao, Hui-juan Ren, Francisco Antonio Guardiola, Kangle Lu, Samad Rahimnejad · 2024 · Aquaculture Reports
58. Insulin Resistance and the Metabolic Syndrome
    Edward Linkner, Corene Humphreys · 2012 · Elsevier eBooks
59. Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease
    Taisa J. Kohut, Jennifer A. Panganiban · 2021 · Clinical Liver Disease
60. Obesity and cancers of the liver, gallbladder, and pancreas
    Matthew J. Sarna, Marcoandrea Giorgi · 2022 · Elsevier eBooks
61. Patient perspective on exercise practices, preferences, and barriers in pediatric nonalcoholic fatty liver disease: A multicenter survey
    Elizabeth L. Yu, Hyeri You, Bryan Rudolph, Jennifer A. Panganiban, Taisa J. Kohut, Henry C. Lin, Amanda C. Fifi, Rasmita Budhathoki, Megan W. Butler, Sabina R. Anderson et al. · 2024 · JPGN Reports
62. Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
    Ling-Zi Chen, Xubin Jing, Xiang Chen, Yanchun Xie, Yun Chen, Xianbin Cai · 2024 · Reviews in Cardiovascular Medicine
63. An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
    Shahid Habib, Andrew Johnson · 2024 · Exploration of Digestive Diseases
64. Steatosis in the Liver
    David Q.‐H. Wang, Piero Portincasa, Brent A. Neuschwander‐Tetri · 2013 · Comprehensive physiology
65. Relative contribution of fat diet and physical inactivity to the development of metabolic syndrome and non-alcoholic fat liver disease in Wistar rats
    António Bovolini, Juliana Garcia, Maria Amparo Andrade, José Alberto Duarte · 2020 · Physiology & Behavior
66. Ameliorating effects of melatonin on high-fat diet induced non-alcoholic fatty liver diseases and their associated pathologies: A comprehensive review
    Songita Ghosh, Razia Khatoon, Swaimanti Sarkar, Debasish Bandyopadhyay · 2023 · Melatonin Research
67. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?
    Venessa Pattullo, Mark W. Douglas, Jacob George · 2011 · Expert Review of Gastroenterology & Hepatology
68. Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
    Jae Young Yu, Hanh Thuy Nguyen, Chul Soon Yong, Hyoung Geun Park, Joon Ho Jun, Jong Oh Kim · 2018 · Laboratory Animal Research · Retracted
69. Fatty Liver, NASH, and Alcoholic Liver Disease
    M. Shimada, Jianfeng Cheng, Arun Jayant Sanyal · 2014 · Elsevier eBooks
70. Retinoid X receptor: the forgotten partner in regulating lipid metabolism?
    Brent A. Neuschwander‐Tetri · 2015 · American Journal of Clinical Nutrition
71. Optimizing nicotinic acid delivery for durable antilipolysis and improved metabolic control
    Tobias Kroon · 2016 · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
72. Quercetin: a natural remedy against high-fat diet-induced liver steatosis in Oncorhynchus mykiss
    Özay Köse · 2025 · Frontiers in Marine Science
73. Nonalcoholic Steatohepatitis Exacerbates Inflammatory Bone Destruction and Macrophage NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Ligature-Induced Periodontitis
    Zijun Wang, Xiaoyue Sun, ZhaoJun Chen, Jingjing Yu, Qing Nie, Zihan Ma, Shuhui Zhou, Ting Li, Hantao Yao, Boxuan Zhao et al. · 2025 · American Journal Of Pathology
74. Induction of hepatic immuno-oxidative stress in broilers by co-exposure to lipopolysaccharide and diquat: An integrated phenotypic and transcriptomic investigation
    Weibing Yang, Xinghuo Liu, Gaofeng Chen, Duan Chen, Hao Zhang, Yueping Chen · 2025 · Poultry Science
75. Serum Lipidome as a Predictor of Significant Liver Fibrosis in Patients with Severe Obesity Undergoing Bariatric Surgery
    Chien-Hung Lu, Yin-Ru Hsieh, Shih-Yi Huang, Weu Wang, Ching-Wen Chang, Binar Panunggal, I‐Wei Chang, Chi-Long Chen, Chun-Chao Chang, Wei‐Yu Kao · 2025 · Obesity Surgery
76. Metformin in Obese Pregnancy: Developmental Reprogramming of Offspring Liver and MASLD Risk by Age and Sex
    Elena Müller-Limberger, Bettina Frederick, Sebastian Hansen, Maria Wohlfarth, Philipp Kasper, Ruth Janoschek, Esther Mahabir, Pascal Fischer, Andrea Mesaros, Martin Purrio et al. · 2025 · Endocrinology
77. Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Oana Albai, Adina Braha, Romulus Zorin Timar, Sandra Lazăr, Simona Daniela Popescu, Bogdan Timar · 2026 · Diabetes Metabolic Syndrome and Obesity
78. Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives
    Seyed Saeed Tamehri Zadeh, Peter Paul Toth, Maciej Banach · 2026 · Frontiers in Pharmacology
79. Effect of Feeding Hay on Nonesterified Fatty Acids in Appetite-Suppressed Pregnant New Zealand White Rabbits
    Jesse W. Veenstra, Adam J. Filgo, Steven Denham · 2019 · Comparative Medicine
80. Management of non-alcoholic fatty liver disease in patients with sarcopenia
    Ching‐Sheng Hsu, Jia‐Horng Kao · 2021 · Expert Opinion on Pharmacotherapy
81. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver
    Yuan Xie, Shaoqing Li, Rourou Chen, Rongbo He, Lijun Qian, Jing Zou, Yan Luo, Ying Zhang, Minjun Ji, Yu Liu · 2022 · Metabolic Syndrome and Related Disorders
82. Effects of lysolecithins on performance, egg quality, blood profiles and liver histopathology in late-phase laying hens
    Zhi He, J. Zeng, M. Wang, Huan Liu, X. Zhou, S. Zhang, Jian He · 2023 · British Poultry Science
83. Promotion Effect of Coexposure to a High-Fat Diet and Nano-Diethylnitrosamine on the Progression of Fatty Liver Malignant Transformation into Liver Cancer
    Xin Yin, Yu-Sang Li, Sha-Zhou Ye, Ting Zhang, Yiwen Zhang, Xi Yang, He‐Bin Tang · 2023 · International Journal of Molecular Sciences
84. Navigating the “specific etiology” steatohepatitis category: Evaluation and management of nonalcohol/nonmetabolic dysfunction–associated steatohepatitis
    Mohammad Qasim Khan, Sara Mohammed Hassan, Blanca Lizaola‐Mayo, Mamatha Bhat, Kymberly D. S. Watt · 2023 · Hepatology
85. Metabolic Effects of Loquat Juice (Eriobotrya japonica Lindl Mkarkeb Variety) on Lipid Homeostasis, Liver Steatosis, and Oxidative Stress in Hyperlipidemic Mice Fed a High-Fat–High-Fructose Diet
    Imane Mokhtari, Thamer Aljutaily, Huda Aljumayi, Khadija S. Radhi, Abdulkarim S. Almutairi, Hassan Barakat, Ibrahim Khalifa, Souliman Amrani, Hicham Harnafi · 2024 · Metabolites
86. Impact of Physical Activity on Digestive System Diseases
    Bartłomiej Zabawa, Jakub Sadowski, Piotr Mól, Łukasz Stanisław Papież, Julia Dołęga, Karol Krzykawski, Tomasz Maciejczyk, Antoni Sieńko, Małgorzata Łabuś, Patrycja Hudzińska · 2024 · Quality in Sport
87. Unraveling the Regulatory Impact of LncRNA Hnf1aos1 on Hepatic Homeostasis in Mice
    Beshoy Armanios, Jing Jin, Holly Kolmel, Ankit Pravin Laddha, Neha Mishra, José Enrique Manautou, Xiao‐bo Zhong · 2025 · Non-Coding RNA
88. Coffee and nonalcoholic fatty liver disease: A review [pdf]
    Grzegorz Nikrandt, Agata Chmurzyńska · 2020 · Acta Scientiarum Polonorum Technologia Alimentaria
89. Aggravation des hépatopathies liées à l’obésité par les xénobiotiques
    Bernard Fromenty · 2014 · Nutrition Clinique et Métabolisme
90. Future Treatments of NASH
    Brent A. Neuschwander‐Tetri · 2016 · Current Hepatology Reports
91. Fatty liver formation in fulminant type 1 diabetes
    Takashi Matsuo, Yoshihiko Ushiroda · 2016 · Endocrinology Diabetes and Metabolism Case Reports
92. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICA
    Joel Vega‐Badillo · 2016 · TIP Revista Especializada en Ciencias Químico-Biológicas
93. Coffee and nonalcoholic fatty liver disease: A review
    Grzegorz Nikrandt, Agata Chmurzyńska · 2020 · Acta Scientiarum Polonorum Technologia Alimentaria
94. Effect of Malus sylvestris Extract on Histopathological Features of Hypercholesterolemic Wistar Rat (Rattus norvegicus) Fatty Liver
    Nadhifa Aufazhafarin · 2021 · Indian Journal of Forensic Medicine & Toxicology
95. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway
    Yan He, Wenhui Yang, Lulu Gan, Shijie Liu, Qing Ni, Yunxia Bi, Tun Han, Qian Liu, Hongyan Chen, Yang Hu et al. · 2021 · Gastroenterología y Hepatología (English Edition)
96. A Non-Invasive Method for Estimating the Severity of Liver Steatosis and the Risk of Fibrosis in Non-Obese Type 2 Diabetes Patients with NAFLD
    Bojan Mitrovic · 2022 · Acta Endocrinologica (Bucharest)
97. Caftaric acid-rich extract from Ocimum basilicum L. modulates lipid profile and prevents lipoprotein oxidation in hyperlipidemic mice
    Imane Mokhtari, Mohamed Harnaf, Souliman Amrani, Dragan Milenković, Hicham Harnaf · 2023 · Physiology and Pharmacology
98. Fatty Liver and Nonalcoholic Steatohepatitis
    Brent A. Neuschwander‐Tetri · 2017 · Elsevier eBooks
99. Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
    Junhee Park, Kyungdo Han, Seung‐Woo Lee, Yeong Jeong Jeon, Sang‐Man Jin, Wonyoung Jung, Yoon Kyoung So, Sang Duk Hong, Dong Wook Shin · 2023 · Cancers
100. Evaluation of efficacy, tolerability and safety of ademetionine in patients with non-alcoholic steatohepatitis with intrahepatic cholestasis syndrome. An open-label, comparative, multicenter, randomized, prospective trial HEPARD
     O. М. Barna, Ya. V. Korost · 2023 · Modern Gastroenterology